This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Stocks With Big Insider Buying

Regado Biosciences

One biopharmaceutical player that insiders are jumping into here is Regado Biosciences (RGDO), which focuses on the discovery and development of antithrombotic drug systems for acute and sub-acute cardiovascular and other indications. Insiders are buying this stock into notable strength, since shares are up 19% so far in 2014.

Regado Biosciences has a market cap of $127 million and an enterprise value of $81 million. This stock trades at a reasonable valuation, with a price-to-book of 2.55. Its estimated growth rate for next year is 1.8%. This is a cash-rich company, since the total cash position on its balance sheet is $43.46 million and its total debt is just $4.41 million.

>>5 Biotech Stocks to Trade in February

Must Read: 3 Stocks Under $10 Making BIg Moves

A beneficial owner just bought 400,000 shares, or $2 million worth of stock, at $5 per share.

From a technical perspective, RGDO is currently trending above its 50-day moving average of $5.52 a share, which is bullish. This stock has been uptrending over the last two months and change, with shares moving higher from its low of $4.56 to its recent high of $6.80 a share. During that uptrend, shares of RGDO have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of RGDO within range of triggering a near-term breakout trade.

If you're bullish on RGDO, then I would look for long-biased trades as long as this stock is trending above some key near-term support levels at $5.30 or at $5 and then once breaks out above some near-term overhead resistance levels at $6.75 to $6.80 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 29,842 shares. If that breakout hits soon, then RGDO will set up to re-test or possibly take out its next major overhead resistance levels at $7.50 to $8, or even $8.50 a share.

2 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
RGDO $8.69 -5.95%
AON $105.78 -0.79%
CNX $14.61 -5.30%
HOLX $34.28 0.81%
MUR $33.43 -4.90%


Chart of I:DJI
DOW 17,750.91 -140.25 -0.78%
S&P 500 2,063.37 -18.06 -0.87%
NASDAQ 4,763.2240 -54.37 -1.13%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs